Chronic hepatitis C is a disease that needs more recognition from the medical community and the general public than it currently receives. This potentially lethal liver disease receives relatively little attention in comparison to well-known diseases like HIV/AIDS. Hepatitis C must be brought to the forefront of medical attention, particularly because more than 170 million people worldwide have been infected, and the incidence of infection is increasing. Legal marijuana, which is commonly used to alleviate the negative side effects of Western medicine’s traditional therapies, has become a hot subject in the medical world recently, with compelling claims from both sides of the debate. In the case of Hepatitis C, it will enable those who are currently undergoing Interferon therapy to cope with the unpleasant side effects. click to see for this.
The most common form of HCV in the United States is genotype 1. However, it has the lowest success rate with Interferon therapy, which could necessitate re-treatment in some cases. One explanation for the poor success rate may be that many patients are unable to complete treatment due to side effects such as headaches, nausea, and extreme depression. Medical marijuana, although having no effect on the infection, could be able to lessen the severity of these effects, allowing more patients to complete treatment.
Many who condemn the use of medical marijuana contend that it has the potential to cause liver damage, negating any treatment benefits.
Regardless of your position on the subject, there is no denying the findings of multiple research demonstrating the beneficial therapeutic effects of medical marijuana on patients with chronic liver disease. Many patients will welcome the ability to complete HCV treatment without experiencing excessive pain or discomfort. In some nations, this divisive treatment is now being used to treat cancer patients and HIV-positive individuals.